Literature DB >> 8775072

Applicability of Iceland spar as a stone model standard for lithotripsy devices.

B F Blitz1, E S Lyon, G S Gerber.   

Abstract

The identification of a universal stone model standard would enable reproducible fragmentation data useful for the design, evaluation, and comparison of various lithotripsy devices. The clinical benefits of such a stone model include the elucidation of setting parameters that would optimize fragmentation strategies. Iceland spar is a pure form of calcite (CaCO3) that was subjected to experimental disintegration by electrohydraulic lithotripsy and extracorporeal shockwave lithotripsy. Iceland spar was fragmented with both lithotripsy methods in a reproducible fashion. The degree of fragmentation was directly related to alterations in either power or shock frequency. Iceland spar is radiopaque, inexpensive, easily obtained, homogenous in composition, and sizable. Iceland spar meets a variety of stone model criteria, warranting its continued investigation as a potential stone model standard.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8775072     DOI: 10.1089/end.1995.9.449

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

1.  Combined Burst Wave Lithotripsy and Ultrasonic Propulsion for Improved Urinary Stone Fragmentation.

Authors:  Theresa A Zwaschka; Justin S Ahn; Bryan W Cunitz; Michael R Bailey; Barbrina Dunmire; Mathew D Sorensen; Jonathan D Harper; Adam D Maxwell
Journal:  J Endourol       Date:  2018-03-20       Impact factor: 2.942

2.  A composite kidney stone phantom with mechanical properties controllable over the range of human kidney stones.

Authors:  W N Simmons; F H Cocks; P Zhong; Glenn Preminger
Journal:  J Mech Behav Biomed Mater       Date:  2009-09-01

3.  The Impact of Dust and Confinement on Fragmentation of Kidney Stones by Shockwave Lithotripsy in Tissue Phantoms.

Authors:  Akshay Randad; Justin Ahn; Michael R Bailey; Wayne Kreider; Jonathan D Harper; Mathew D Sorensen; Adam D Maxwell
Journal:  J Endourol       Date:  2019-02-01       Impact factor: 2.942

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.